Cardiometabolic risk in Algeria: past and present

Abstract

Algeria, like all emerging countries, has been going through a health transition over the past 30 years or so, characterized by a drop in mortality rates, an increase in life expectancy and a change in the causes of death in favor of chronic non-communicable diseases. In the past, the country mainly faced infectious diseases such as typhoid, cholera and malaria. The prevalence of the latter has been significantly reduced thanks to the many social health and vaccination programs undertaken by the health authorities. As a result of this epidemiological transition, we are witnessing a growing increase in the incidence of non-communicable diseases, mainly represented by cardiovascular diseases, diabetes, obesity and cancer. According to the results of the latest national survey on the measurement of risk factors for non-communicable diseases (the Who StepWise approach), the prevalence of diabetes is close to 14.4% while the rate of obesity and overweight exceeds 50% of the population. High blood pressure has reached a prevalence rate of 23.6%. These diseases represent a real threat to our country's health, social and economic situation; they will lead to greater demands on health facilities and require more resources for intervention.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Aboa-Éboulé C, Brisson C, Maunsell E et al (2011) Effort-reward imbalance at work and recurrent coronary heart disease events: a 4 year prospective study of post-myocardial infarction patients. Psychosom Med 73(6):436–447

    Article  Google Scholar 

  2. 2.

    Järvholm B (2012) How should methods for return to work be evaluated? Scand J Work Environ Health 38(2):89–91

    Article  Google Scholar 

  3. 3.

    Houti L, Chougrani S (2009) La transition epidemiologique en Algerie. Les cahiers du CRASC 19:73–93

    Google Scholar 

  4. 4.

    United Nations Department of Economic and Social Affairs/Population Division. World population prospects: the 2017 revision, Volume II: Demographic profiles

  5. 5.

    Office National des Statistiques algérien. https://www.ons.dz/-Demographie-.html. Accessed 17 Oct 2019

  6. 6.

    Omran AR (1971) The epidemiologic transition: a theory of the epidemiology of population change. Milkbank Mem Fund Quart 29:509–538

    Article  Google Scholar 

  7. 7.

    Maire B, Lioret S, Gartner A et al (2002) Transition nutritionnelle et maladies chroniques non-transmissibles liées à l’alimentation dans les pays en développement. Cahiers d'études et de recherches francophones/Santé 12(1):45–55

    Google Scholar 

  8. 8.

    Atek M, Ouchfoun A, Laid Y et al (2007) La transition épidémiologique et le système de santé en Algérie: Enquête Nationale Santé 2005. Institut National de Santé Publique Algérie & Projet TAHINA. (Contrat no ICA3-CT-2002-10011)Ed

  9. 9.

    Alberti KG, Zimmet P, Shaw J, IDF Epidemiology Task Force Consensus Group (2005) The metabolic syndrome—a new worldwide definition. Lancet 366:1059–1062

    Article  Google Scholar 

  10. 10.

    Expert Panel on Detection (2001) Evaluation and treatment of high blood cholesterol in adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol (Adult Treatment Panel III). JAMA 285:2486–2497

    Article  Google Scholar 

  11. 11.

    Nejjari C, Arharbi M, Chentir MT et al (2013) Epidemiological Trial of Hypertension in North Africa (ETHNA): an international multicentre study in Algeria, Morocco and Tunisia. J Hypertens 31(1):49–62

    CAS  PubMed  Google Scholar 

  12. 12.

    Brouri M, Ouadahi N, Nibouche D et al (2018) Facteurs de risque cardio-vasculaires en Algérie. Une analyse du sous-groupe de l’étude «Africa/Middle East Cardiovascular Epidemiological». Ann Cardiol Angeiol 67(2):61–66

    CAS  Article  Google Scholar 

  13. 13.

    Benkhedda S, Chibane A, Temmar M et al (2005) Report SAHA. J Hypertens. 23(suppl 2)

  14. 14.

    Step wise OMS. Rapport MSRRH, Algerie 2004 https://www.who.int/chp/steps/STEPS_Algeria_Data.pdf. Accessed 17 Oct 2019

  15. 15.

    Biad A, Chibane A, Makhlouf L et al (2009) ESH 16e congress, Milano, Juin 2009, ESH book, S P41 p 2017

  16. 16.

    Yahia-Berrouiguet A, Benyoucef M, Meguenni K et al (2009) Enquête sur la prévalence des facteurs de risque de maladies cardiovasculaires à Tlemcen (Algérie). Médecine des Maladies Métaboliques 3(3):313–319

    Article  Google Scholar 

  17. 17.

    Temmar M, Labat C, Benkhedda S et al (2007) Prevalence and determinants of hypertension in the Algerian Sahara. J Hypertens 25:2218–2226

    CAS  Article  Google Scholar 

  18. 18.

    Zaamouche A, Lakhal A, Belatrache C et al (2013) Obésité et prehypertension arterielle. Diabetes Metabol 39:126–129

    Article  Google Scholar 

  19. 19.

    Hamida F, Temmar M, Atif ML et al (2015) Syndrome métabolique: prévalence et caractéristiques clinico-biologiques dans une population du Sahara algérien. Diabetes et Metabolism 41(1):A65

    Article  Google Scholar 

  20. 20.

    Hamida F, Temmar M, Atif ML et al (2013) Prévalence de l’hypertension artérielle dans l’oasis d’El-Menia, Algérie, et profil métabolique de la population. Annales de Cardiologie et d'Angéiologie 62(3):172–178

    CAS  Article  Google Scholar 

  21. 21.

    Mammeri A Prévalence et facteurs déterminants de la préhypertension en consultation de médecine générale à Alger. https://indexmedicus.afro.who.int/aim/opac_css/doc_num.php?explnum_id=71181. Accessed 17 Oct 2019

  22. 22.

    Boukli HL, Khelil MA, Chabane Sari D et al (2017) Prevalence of cardiovascular risk factors in urban and rural communities in the Wilaya of Tlemcen (Algeria): a comparative study. Rev Epidemiol Sante Publique 65(4):277–284

    Article  Google Scholar 

  23. 23.

    Enquête nationale sur la mesure du poids des facteurs de risque des Maladies Non Transmissibles selon l’approche STEPwise de l’OMS. Principaux résultats. https://www.afro.who.int/fr/publications/enquete-nationale-sur-la-mesure-du-poids-des-facteurs-de-risque-des-maladies-nontransmissibles. Accessed 17 Oct 2019

  24. 24.

    Taleb S, Oulamara H, Agli AN (2013) Prevalence of overweight and obesity in school children in Tebessa [eastern Algeria] between 1995 and 2007. East Mediterr Health J 19:649–656

    CAS  Article  Google Scholar 

  25. 25.

    Bahchachi N, Dahel-Mekhancha CC, Rolland-Cachera MF et al (2017) BMI charts of Algerian children and adolescents (6–18 years). Arch Pediatr 24(12):1205–1213

    CAS  Article  Google Scholar 

  26. 26.

    Mehenni F, Tirtouil Meddah A, Mullié C et al (2016) Prevalence of obesity, diabetes and factors associated among Mascarien primary school children (West Algeria). J Appl Environ Biol Sci 6(8):40–46

    Google Scholar 

  27. 27.

    Niar S, Naceur M, Bessahraoui M et al (2015) Epidemiology of children type 1 diabetes in the department of Oran (Algeria), 1975–2014. Médecine des maladies Métaboliques 9(5):529–532

    Article  Google Scholar 

  28. 28.

    Rapport OMS 2018. Les 10 principales causes de mortalité. https://www.who.int/fr/news-room/fact-sheets/detail/the-top-10-causes-of-death. Accessed July 2019

  29. 29.

    Benbekhti S, Saïm H, Chabni NS et al (2016) La mortalité hospitalière au centre hospitalier universitaire de Tlemcen, Algérie, 2013–2014. Revue d'Épidémiologie et de Santé Publique 64(4):256–257

    Article  Google Scholar 

  30. 30.

    World Health Organization-Non-Communicable diseases-Country profiles (2014) https://who.int/gho/mortality_burden_disease. Accessed 17 Oct 2019

  31. 31.

    Plan stratégique national multisectoriel de lutte intégrée contre les facteurs de risque des maladies non transmissibles 2015–2019 https://extranet.who.int/ncdccs/Data/DZA_B3_plan%20strat%C3%A9gique_MNT2015-2019.pdf. Accessed 17 Oct 2019

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Amel Mammeri.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Statement of human and animal rights

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

For this type of study, formal consent is not required.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Mammeri, A., Tebaibia, A. Cardiometabolic risk in Algeria: past and present. Intern Emerg Med 15, 531–535 (2020). https://doi.org/10.1007/s11739-019-02207-z

Download citation

Keywords

  • Non-communicable diseases
  • Cardiometabolic risk
  • Cardiovascular diseases